We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · September 25, 2019

Prognostic Significance of MYC Rearrangement and Translocation Partner in DLBCL

Journal of Clinical Oncology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Clinical Oncology
Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium
J. Clin. Oncol 2019 Sep 09;[EPub Ahead of Print], A Rosenwald, S Bens, R Advani, S Barrans, C Copie-Bergman, MH Elsensohn, Y Natkunam, M Calaminici, B Sander, M Baia, A Smith, D Painter, L Pham, S Zhao, M Ziepert, ES Jordanova, TJ Molina, MJ Kersten, E Kimby, W Klapper, J Raemaekers, N Schmitz, F Jardin, WBC Stevens, E Hoster, A Hagenbeek, JG Gribben, R Siebert, RD Gascoyne, DW Scott, P Gaulard, G Salles, C Burton, D de Jong, LH Sehn, D Maucort-Boulch

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading